Global Genomics Market (By Products & Services – Instruments/Systems, Consumables and Services, By Technology- PCR (Polymerase Chain Reaction), DNA Microarray, Sequencing, Nucleic Acid Extraction & Purification and Others, By Application – Diagnostics, Personalized Medicine, Drug Discovery & Development, Agriculture & Animal Research and Others, By Process- Library Preparation, Gene Sequencing and data analysis, By End-User- Hospital & Clinics, Research enters, Government & academic Institutes, Pharmaceutical & Biotechnology Companies and Others); – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025
The report covers the analysis and forecast of the global genomics market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Bn).
The study provides a detailed view of the global genomics market, by segmenting it based on, product and services, technology, application, process, end-user and regional demand. The products and services type segment include instruments/systems, consumables and services, while based on technology, it includes PCR (polymerase chain reaction), DNA microarray, DNA sequencing, nucleic acid extraction and purification and others (genotyping and gene editing). On the other hand, application wise, the segments are diagnostics, personalized medicine, drug discovery and development, agriculture and animal research and others and by process the market is classified into library preparation, gene sequencing and data analysis. By end-user, the genomics market can be segmented into hospital and clinics, research centers, government and academic institutes, pharmaceutical and biotechnology companies and others (NGO’s and agri-genomics organizations).
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa. Market dynamics for each region has been provided in the report.
The study provides a detailed view of the global genomics market, by segmenting it based on, product and services, technology, application, process, end-user and regional demand. The products and services type segment include instruments/systems, consumables and services, while based on technology, it includes PCR (polymerase chain reaction), DNA microarray, DNA sequencing, nucleic acid extraction and purification and others (genotyping and gene editing). On the other hand, application wise, the segments are diagnostics, personalized medicine, drug discovery and development, agriculture and animal research and others and by process the market is classified into library preparation, gene sequencing and data analysis. By end-user, the genomics market can be segmented into hospital and clinics, research centers, government and academic institutes, pharmaceutical and biotechnology companies and others (NGO’s and agri-genomics organizations).
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa. Market dynamics for each region has been provided in the report.
1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF GLOBAL GENOMICS MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL GENOMICS MARKET SNAPSHOT
3.2 GLOBAL GENOMICS MARKET REVENUE, 2017 – 2025 (US$ BN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS, %, 2017
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL GENOMICS MARKET, BY PRODUCTS AND SERVICES
5.1 OVERVIEW
5.2 GLOBAL GENOMICS MARKET FOR INSTRUMENTS/SYSTEMS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
5.3 GLOBAL GENOMICS MARKET FOR, CONSUMABLES, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
5.4 GLOBAL GENOMICS MARKET FOR SERVICES, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6 GLOBAL GENOMICS MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 GLOBAL GENOMICS MARKET FOR PCR (POLYMERASE CHAIN REACTION), VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6.3 GLOBAL GENOMICS MARKET FOR DNA MICROARRAY, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6.4 GLOBAL GENOMICS MARKET FOR DNA SEQUENCING, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6.5 GLOBAL GENOMICS MARKET FOR, NUCLEIC ACID EXTRACTION AND PURIFICATION, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6.6 GLOBAL GENOMICS MARKET FOR OTHERS (GENOTYPING AND GENE EDITING), VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7 GLOBAL GENOMICS MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 GLOBAL GENOMICS MARKET FOR, DIAGNOSTICS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7.3 GLOBAL GENOMICS MARKET FOR PERSONALIZED MEDICINE, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7.4 GLOBAL GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7.5 GLOBAL GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7.6 GLOBAL GENOMICS MARKET FOR OTHERS (COALMINES,BIOFUELS AND MARINE RESEARCH) VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
8 GLOBAL GENOMICS MARKET, BY PROCESS
8.1 OVERVIEW
8.2 GLOBAL GENOMICS MARKET FOR LIBRARY PREPARATION, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
8.3 GLOBAL GENOMICS MARKET FOR GENE SEQUENCING, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
8.4 GLOBAL GENOMICS MARKET FOR DATA ANALYSIS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9 GLOBAL GENOMICS MARKET, BY END-USER
9.1 OVERVIEW
9.2 GLOBAL GENOMICS MARKET FOR, HOSPITALS AND CLINICS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9.3 GLOBAL GENOMICS MARKET FOR RESEARCH CENTERS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9.4 GLOBAL GENOMICS MARKET FOR GOVERNMENT AND ACADEMIC INSTITUTES, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9.5 GLOBAL GENOMICS MARKET FOR PHARMACEUTICALS AND BIOTECHNOLOGICAL COMPANIES, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9.6 GLOBAL GENOMICS MARKET FOR OTHERS (SUCH AS NGO’S AND AGRI-GENOMICS ORGANIZATIONS) VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
10 GLOBAL GENOMICS MARKET, BY GEOGRAPHY
10.1 NORTH AMERICA
10.1.1 MARKET DYNAMICS
10.1.1.1 Drivers
10.1.1.2 Restraints
10.1.1.3 Opportunity
10.1.2 U.S.
10.1.3 CANADA
10.1.4 MEXICO
10.2 EUROPE
10.2.1 MARKET DYNAMICS
10.2.1.1 Drivers
10.2.1.2 Restraints
10.2.1.3 Opportunity
10.2.2 U.K.
10.2.3 ITALY
10.2.4 FRANCE
10.2.5 GERMANY
10.2.6 RUSSIA
10.2.7 SPAIN
10.2.8 REST OF EUROPE
10.3 ASIA PACIFIC
10.3.1 MARKET DYNAMICS
10.3.1.1 Drivers
10.3.1.2 Restraints
10.3.1.3 Opportunity
10.3.2 INDIA
10.3.3 CHINA
10.3.4 JAPAN
10.3.5 AUSTRALIA
10.3.6 REST OF ASIA PACIFIC
10.4 MIDDLE EAST AND AFRICA
10.4.1 MARKET DYNAMICS
10.4.1.1 Drivers
10.4.1.2 Restraints
10.4.1.3 Opportunity
10.4.2 GCC
10.4.3 SOUTH AFRICA
10.4.4 REST OF MIDDLE EAST AND AFRICA
10.5 LATIN AMERICA
10.5.1 MARKET DYNAMICS
10.5.1.1 Drivers
10.5.1.2 Restraints
10.5.1.3 Opportunity
10.5.2 BRAZIL
10.5.3 REST OF LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 NEW PRODUCT LAUNCHES
12 GLOBAL GENOMICS MARKET, BY COMPANY
12.1 INTRODUCTION
12.2 AGILENT TECHNOLOGIES
12.2.1 BUSINESS OVERVIEW
12.2.2 PRODUCTS AND SERVICES
12.2.3 KEY STRATEGY
12.2.4 RECENT DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 OUR COMPANY VIEW
12.3 AFFYMETRIX, INC.
12.3.1 BUSINESS OVERVIEW
12.3.2 PRODUCTS AND SERVICES
12.3.3 KEY STRATEGY
12.3.4 RECENT DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 OUR COMPANY VIEW
12.4 BEIJING GENOMICS INSTITUTE (BGI)
12.4.1 BUSINESS OVERVIEW
12.4.2 PRODUCTS AND SERVICES
12.4.3 KEY STRATEGY
12.4.4 RECENT DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 OUR COMPANY VIEW
12.5 DANAHER
12.5.1 BUSINESS OVERVIEW
12.5.2 PRODUCTS AND SERVICES
12.5.3 KEY STRATEGY
12.5.4 RECENT DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 OUR COMPANY VIEW
12.6 EUROFINS SCIENTIFIC
12.6.1 BUSINESS OVERVIEW
12.6.2 PRODUCTS AND SERVICES
12.6.3 KEY STRATEGY
12.6.4 RECENT DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.6.6 OUR COMPANY VIEW
12.7 EPPENDORF
12.7.1 BUSINESS OVERVIEW
12.7.2 PRODUCTS AND SERVICES
12.7.3 KEY STRATEGY
12.7.4 RECENT DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 OUR COMPANY VIEW
12.8 F. HOFFMANN-LA ROCHE
12.8.1 BUSINESS OVERVIEW
12.8.2 PRODUCTS AND SERVICES
12.8.3 KEY STRATEGY
12.8.4 RECENT DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 OUR COMPANY VIEW
12.9 GE HEALTHCARE
12.9.1 BUSINESS OVERVIEW
12.9.2 PRODUCTS AND SERVICES
12.9.3 KEY STRATEGY
12.9.4 RECENT DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 OUR COMPANY VIEW
12.10 ILLUMINA INC.
12.10.1 BUSINESS OVERVIEW
12.10.2 PRODUCTS AND SERVICES
12.10.3 KEY STRATEGY
12.10.4 RECENT DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.10.6 OUR COMPANY VIEW
12.11 LIFE TECHNOLOGIES, INC.
12.11.1 BUSINESS OVERVIEW
12.11.2 PRODUCTS AND SERVICES
12.11.3 KEY STRATEGY
12.11.4 RECENT DEVELOPMENTS
12.11.5 SWOT ANALYSIS
12.11.6 OUR COMPANY VIEW
12.12 OXFORD NANOPORE TECHNOLOGIES
12.12.1 BUSINESS OVERVIEW
12.12.2 PRODUCTS AND SERVICES
12.12.3 KEY STRATEGY
12.12.4 RECENT DEVELOPMENTS
12.12.5 SWOT ANALYSIS
12.12.6 OUR COMPANY VIEW
12.13 PACIFIC BIOSCIENCES OF CALIFORNIA
12.13.1 BUSINESS OVERVIEW
12.13.2 PRODUCTS AND SERVICES
12.13.3 KEY STRATEGY
12.13.4 RECENT DEVELOPMENTS
12.13.5 SWOT ANALYSIS
12.13.6 OUR COMPANY VIEW
12.14 QIAGEN
12.14.1 BUSINESS OVERVIEW
12.14.2 PRODUCTS AND SERVICES
12.14.3 KEY STRATEGY
12.14.4 RECENT DEVELOPMENTS
12.14.5 SWOT ANALYSIS
12.14.6 OUR COMPANY VIEW
12.15 ROCHE DIAGNOSTICS
12.15.1 BUSINESS OVERVIEW
12.15.2 PRODUCTS AND SERVICES
12.15.3 KEY STRATEGY
12.15.4 RECENT DEVELOPMENTS
12.15.5 SWOT ANALYSIS
12.15.6 OUR COMPANY VIEW
12.16 THERMO FISHER SCIENTIFIC
12.16.1 BUSINESS OVERVIEW
12.16.2 PRODUCTS AND SERVICES
12.16.3 KEY STRATEGY
12.16.4 RECENT DEVELOPMENTS
12.16.5 SWOT ANALYSIS
12.16.6 OUR COMPANY VIEW
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF GLOBAL GENOMICS MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL GENOMICS MARKET SNAPSHOT
3.2 GLOBAL GENOMICS MARKET REVENUE, 2017 – 2025 (US$ BN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS, %, 2017
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL GENOMICS MARKET, BY PRODUCTS AND SERVICES
5.1 OVERVIEW
5.2 GLOBAL GENOMICS MARKET FOR INSTRUMENTS/SYSTEMS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
5.3 GLOBAL GENOMICS MARKET FOR, CONSUMABLES, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
5.4 GLOBAL GENOMICS MARKET FOR SERVICES, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6 GLOBAL GENOMICS MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 GLOBAL GENOMICS MARKET FOR PCR (POLYMERASE CHAIN REACTION), VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6.3 GLOBAL GENOMICS MARKET FOR DNA MICROARRAY, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6.4 GLOBAL GENOMICS MARKET FOR DNA SEQUENCING, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6.5 GLOBAL GENOMICS MARKET FOR, NUCLEIC ACID EXTRACTION AND PURIFICATION, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6.6 GLOBAL GENOMICS MARKET FOR OTHERS (GENOTYPING AND GENE EDITING), VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7 GLOBAL GENOMICS MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 GLOBAL GENOMICS MARKET FOR, DIAGNOSTICS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7.3 GLOBAL GENOMICS MARKET FOR PERSONALIZED MEDICINE, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7.4 GLOBAL GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7.5 GLOBAL GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7.6 GLOBAL GENOMICS MARKET FOR OTHERS (COALMINES,BIOFUELS AND MARINE RESEARCH) VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
8 GLOBAL GENOMICS MARKET, BY PROCESS
8.1 OVERVIEW
8.2 GLOBAL GENOMICS MARKET FOR LIBRARY PREPARATION, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
8.3 GLOBAL GENOMICS MARKET FOR GENE SEQUENCING, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
8.4 GLOBAL GENOMICS MARKET FOR DATA ANALYSIS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9 GLOBAL GENOMICS MARKET, BY END-USER
9.1 OVERVIEW
9.2 GLOBAL GENOMICS MARKET FOR, HOSPITALS AND CLINICS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9.3 GLOBAL GENOMICS MARKET FOR RESEARCH CENTERS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9.4 GLOBAL GENOMICS MARKET FOR GOVERNMENT AND ACADEMIC INSTITUTES, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9.5 GLOBAL GENOMICS MARKET FOR PHARMACEUTICALS AND BIOTECHNOLOGICAL COMPANIES, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9.6 GLOBAL GENOMICS MARKET FOR OTHERS (SUCH AS NGO’S AND AGRI-GENOMICS ORGANIZATIONS) VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
10 GLOBAL GENOMICS MARKET, BY GEOGRAPHY
10.1 NORTH AMERICA
10.1.1 MARKET DYNAMICS
10.1.1.1 Drivers
10.1.1.2 Restraints
10.1.1.3 Opportunity
10.1.2 U.S.
10.1.3 CANADA
10.1.4 MEXICO
10.2 EUROPE
10.2.1 MARKET DYNAMICS
10.2.1.1 Drivers
10.2.1.2 Restraints
10.2.1.3 Opportunity
10.2.2 U.K.
10.2.3 ITALY
10.2.4 FRANCE
10.2.5 GERMANY
10.2.6 RUSSIA
10.2.7 SPAIN
10.2.8 REST OF EUROPE
10.3 ASIA PACIFIC
10.3.1 MARKET DYNAMICS
10.3.1.1 Drivers
10.3.1.2 Restraints
10.3.1.3 Opportunity
10.3.2 INDIA
10.3.3 CHINA
10.3.4 JAPAN
10.3.5 AUSTRALIA
10.3.6 REST OF ASIA PACIFIC
10.4 MIDDLE EAST AND AFRICA
10.4.1 MARKET DYNAMICS
10.4.1.1 Drivers
10.4.1.2 Restraints
10.4.1.3 Opportunity
10.4.2 GCC
10.4.3 SOUTH AFRICA
10.4.4 REST OF MIDDLE EAST AND AFRICA
10.5 LATIN AMERICA
10.5.1 MARKET DYNAMICS
10.5.1.1 Drivers
10.5.1.2 Restraints
10.5.1.3 Opportunity
10.5.2 BRAZIL
10.5.3 REST OF LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 NEW PRODUCT LAUNCHES
12 GLOBAL GENOMICS MARKET, BY COMPANY
12.1 INTRODUCTION
12.2 AGILENT TECHNOLOGIES
12.2.1 BUSINESS OVERVIEW
12.2.2 PRODUCTS AND SERVICES
12.2.3 KEY STRATEGY
12.2.4 RECENT DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 OUR COMPANY VIEW
12.3 AFFYMETRIX, INC.
12.3.1 BUSINESS OVERVIEW
12.3.2 PRODUCTS AND SERVICES
12.3.3 KEY STRATEGY
12.3.4 RECENT DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 OUR COMPANY VIEW
12.4 BEIJING GENOMICS INSTITUTE (BGI)
12.4.1 BUSINESS OVERVIEW
12.4.2 PRODUCTS AND SERVICES
12.4.3 KEY STRATEGY
12.4.4 RECENT DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 OUR COMPANY VIEW
12.5 DANAHER
12.5.1 BUSINESS OVERVIEW
12.5.2 PRODUCTS AND SERVICES
12.5.3 KEY STRATEGY
12.5.4 RECENT DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 OUR COMPANY VIEW
12.6 EUROFINS SCIENTIFIC
12.6.1 BUSINESS OVERVIEW
12.6.2 PRODUCTS AND SERVICES
12.6.3 KEY STRATEGY
12.6.4 RECENT DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.6.6 OUR COMPANY VIEW
12.7 EPPENDORF
12.7.1 BUSINESS OVERVIEW
12.7.2 PRODUCTS AND SERVICES
12.7.3 KEY STRATEGY
12.7.4 RECENT DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 OUR COMPANY VIEW
12.8 F. HOFFMANN-LA ROCHE
12.8.1 BUSINESS OVERVIEW
12.8.2 PRODUCTS AND SERVICES
12.8.3 KEY STRATEGY
12.8.4 RECENT DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 OUR COMPANY VIEW
12.9 GE HEALTHCARE
12.9.1 BUSINESS OVERVIEW
12.9.2 PRODUCTS AND SERVICES
12.9.3 KEY STRATEGY
12.9.4 RECENT DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 OUR COMPANY VIEW
12.10 ILLUMINA INC.
12.10.1 BUSINESS OVERVIEW
12.10.2 PRODUCTS AND SERVICES
12.10.3 KEY STRATEGY
12.10.4 RECENT DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.10.6 OUR COMPANY VIEW
12.11 LIFE TECHNOLOGIES, INC.
12.11.1 BUSINESS OVERVIEW
12.11.2 PRODUCTS AND SERVICES
12.11.3 KEY STRATEGY
12.11.4 RECENT DEVELOPMENTS
12.11.5 SWOT ANALYSIS
12.11.6 OUR COMPANY VIEW
12.12 OXFORD NANOPORE TECHNOLOGIES
12.12.1 BUSINESS OVERVIEW
12.12.2 PRODUCTS AND SERVICES
12.12.3 KEY STRATEGY
12.12.4 RECENT DEVELOPMENTS
12.12.5 SWOT ANALYSIS
12.12.6 OUR COMPANY VIEW
12.13 PACIFIC BIOSCIENCES OF CALIFORNIA
12.13.1 BUSINESS OVERVIEW
12.13.2 PRODUCTS AND SERVICES
12.13.3 KEY STRATEGY
12.13.4 RECENT DEVELOPMENTS
12.13.5 SWOT ANALYSIS
12.13.6 OUR COMPANY VIEW
12.14 QIAGEN
12.14.1 BUSINESS OVERVIEW
12.14.2 PRODUCTS AND SERVICES
12.14.3 KEY STRATEGY
12.14.4 RECENT DEVELOPMENTS
12.14.5 SWOT ANALYSIS
12.14.6 OUR COMPANY VIEW
12.15 ROCHE DIAGNOSTICS
12.15.1 BUSINESS OVERVIEW
12.15.2 PRODUCTS AND SERVICES
12.15.3 KEY STRATEGY
12.15.4 RECENT DEVELOPMENTS
12.15.5 SWOT ANALYSIS
12.15.6 OUR COMPANY VIEW
12.16 THERMO FISHER SCIENTIFIC
12.16.1 BUSINESS OVERVIEW
12.16.2 PRODUCTS AND SERVICES
12.16.3 KEY STRATEGY
12.16.4 RECENT DEVELOPMENTS
12.16.5 SWOT ANALYSIS
12.16.6 OUR COMPANY VIEW
